209 related articles for article (PubMed ID: 30006634)
1. Probiotics in human gut microbiota can degrade host glycosaminoglycans.
Kawai K; Kamochi R; Oiki S; Murata K; Hashimoto W
Sci Rep; 2018 Jul; 8(1):10674. PubMed ID: 30006634
[TBL] [Abstract][Full Text] [Related]
2. Hungatella hathewayi, an Efficient Glycosaminoglycan-Degrading
Rawat PS; Li Y; Zhang W; Meng X; Liu W
Appl Environ Microbiol; 2022 Nov; 88(22):e0154622. PubMed ID: 36342199
[TBL] [Abstract][Full Text] [Related]
3. Metabolic fate of unsaturated glucuronic/iduronic acids from glycosaminoglycans: molecular identification and structure determination of streptococcal isomerase and dehydrogenase.
Maruyama Y; Oiki S; Takase R; Mikami B; Murata K; Hashimoto W
J Biol Chem; 2015 Mar; 290(10):6281-92. PubMed ID: 25605731
[TBL] [Abstract][Full Text] [Related]
4. Utilization of glycosaminoglycans by the human gut microbiota: participating bacteria and their enzymatic machineries.
Rawat PS; Seyed Hameed AS; Meng X; Liu W
Gut Microbes; 2022; 14(1):2068367. PubMed ID: 35482895
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structures of
Iwase H; Yamamoto Y; Yamada A; Kawai K; Oiki S; Watanabe D; Mikami B; Takase R; Hashimoto W
J Appl Glycosci (1999); 2023; 70(4):99-107. PubMed ID: 38239764
[TBL] [Abstract][Full Text] [Related]
6. Isolation and identification of mucin-degrading bacteria originated from human faeces and their potential probiotic efficacy according to host-microbiome enterotype.
Yuan H; Zhou J; Li N; Wu X; Huang S; Park S
J Appl Microbiol; 2022 Aug; 133(2):362-374. PubMed ID: 35365862
[TBL] [Abstract][Full Text] [Related]
7. The human gut microbe
Ndeh D; Munoz Munoz J; Cartmell A; Bulmer D; Wills C; Henrissat B; Gray J
J Biol Chem; 2018 Nov; 293(46):17906-17916. PubMed ID: 30262663
[TBL] [Abstract][Full Text] [Related]
8. Degradation of acharan sulfate and heparin by Bacteroides stercoris HJ-15, a human intestinal bacterium.
Kim DH; Kim BT; Park SY; Kim NY; Han MJ; Shin KH; Kim WS; Kim YS
Arch Pharm Res; 1998 Oct; 21(5):576-80. PubMed ID: 9875498
[TBL] [Abstract][Full Text] [Related]
9. Enhanced propagation of Granulicatella adiacens from human oral microbiota by hyaluronan.
Yabuuchi S; Oiki S; Minami S; Takase R; Watanabe D; Hashimoto W
Sci Rep; 2022 Jun; 12(1):10948. PubMed ID: 35768476
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a Bacteroides species from human intestine that degrades glycosaminoglycans.
Ahn MY; Shin KH; Kim DH; Jung EA; Toida T; Linhardt RJ; Kim YS
Can J Microbiol; 1998 May; 44(5):423-9. PubMed ID: 9699297
[TBL] [Abstract][Full Text] [Related]
11. Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase.
Ulmer JE; Vilén EM; Namburi RB; Benjdia A; Beneteau J; Malleron A; Bonnaffé D; Driguez PA; Descroix K; Lassalle G; Le Narvor C; Sandström C; Spillmann D; Berteau O
J Biol Chem; 2014 Aug; 289(35):24289-303. PubMed ID: 25002587
[TBL] [Abstract][Full Text] [Related]
12. A Semi-Quantitative Assay to Measure Glycosaminoglycan Degradation by the Urinary Microbiota.
Nguyen VH; Khan F; Shipman BM; Neugent ML; Hulyalkar NV; Cha NY; Zimmern PE; De Nisco NJ
Front Cell Infect Microbiol; 2021; 11():803409. PubMed ID: 35047421
[TBL] [Abstract][Full Text] [Related]
13. Metabolism mechanism of glycosaminoglycans by the gut microbiota: Bacteroides and lactic acid bacteria: A review.
Dong J; Cui Y; Qu X
Carbohydr Polym; 2024 May; 332():121905. PubMed ID: 38431412
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into E. coli's hexuronate metabolism: KduI facilitates the conversion of galacturonate and glucuronate under osmotic stress conditions.
Rothe M; Alpert C; Loh G; Blaut M
PLoS One; 2013; 8(2):e56906. PubMed ID: 23437267
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.
Rother S; Samsonov SA; Hofmann T; Blaszkiewicz J; Köhling S; Moeller S; Schnabelrauch M; Rademann J; Kalkhof S; von Bergen M; Pisabarro MT; Scharnweber D; Hintze V
Acta Biomater; 2016 Nov; 45():143-154. PubMed ID: 27545813
[TBL] [Abstract][Full Text] [Related]
16. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome.
Nagpal R; Wang S; Ahmadi S; Hayes J; Gagliano J; Subashchandrabose S; Kitzman DW; Becton T; Read R; Yadav H
Sci Rep; 2018 Aug; 8(1):12649. PubMed ID: 30139941
[TBL] [Abstract][Full Text] [Related]
17. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
18. Protective activity of probiotic bacteria against 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine (PhIP) - an in vitro study.
Nowak A; Czyżowska A; Stańczyk M
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(11):1927-38. PubMed ID: 26295367
[TBL] [Abstract][Full Text] [Related]
19. Bacteroides salyersiae is a potent chondroitin sulfate-degrading species in the human gut microbiota.
Wang Y; Ma M; Dai W; Shang Q; Yu G
Microbiome; 2024 Feb; 12(1):41. PubMed ID: 38419055
[TBL] [Abstract][Full Text] [Related]
20. A bacterial ABC transporter enables import of mammalian host glycosaminoglycans.
Oiki S; Mikami B; Maruyama Y; Murata K; Hashimoto W
Sci Rep; 2017 Apr; 7(1):1069. PubMed ID: 28432302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
